|
|
||||||||
J Thorac Cardiovasc Surg 1999;118:916-923
© 1999 Mosby, Inc.
GENERAL THORACIC SURGERY |
From Allegheny University Hospitals, Allegheny General, Pittsburgh, Paa; University of Chicago, Chicago, Illb; St Louis University, St Louis, Moc; Southern Illinois University, Springfield, Illd; Medical Center Dallas, Dallas, Texe; and the University of Pittsburgh, Pittsburgh, Pa.f
Address for reprints: Rodney J. Landreneau, MD, Allegheny University Hospitals, Allegheny General Thoracic Surgery, O2 Level South Tower, 320 East North Ave, Pittsburgh, PA 15212-4772.
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
| Patients and methods |
|---|
|
|
|---|
Clinical features.
The diagnosis of achalasia was made by assessing the combined results of the patients clinical history, esophagogastroduodenoscopy, barium esophagogram, and esophageal manometry. All 58 patients had preoperative dysphagia and 45 (78%) of the 58 patients described important regurgitation symptoms. Weight loss greater than 10 pounds was noted in 29 patients (47%). Respiratory complications were also common (aspiration, recurrent pneumonia, bronchitis), occurring in 13 patients (22%). Postprandial chest pain was an important primary symptom described by 21 patients (36%), and 35 patients (60%) had a sensation of heartburn. Interestingly, this heartburn sensation was poorly relieved with antacid or antisecretory therapy. The average duration of symptoms was 59.9 ± 56.5 months with a range of 3 to 240 months. Barium esophagograms demonstrated an average esophageal body diameter of 6 cm, and important tortuosity in the body of the esophagus was noted in 9 (16%) of the 58 patients. Manometric studies demonstrated an average lower esophageal sphincter pressure of 31.5 ± 14.9 mm Hg. A lack of peristaltic contraction and the absence of lower esophageal sphincter relaxation in response to swallowing was uniformly noted. Sixty-six percent of patients had absent or very poor esophageal body contractility identified at esophageal manometric assessment. Forty-seven patients (81%) had undergone at least 1 previous pneumatic dilation and 8 patients (14%) had previously received botulinum toxin administration. One patient had undergone a previous open transthoracic myotomy 12 years earlier.
Surgical approaches
Laparoscopic approach.
After careful induction of general anesthesia particularly aimed at avoiding aspiration, esophagoscopy is performed to remove any residual debris within the esophagus and to inspect the distal esophagus and rule out any other pathologic condition that may be mimicking achalasia (ie, pseudoachalasia caused by a malignant tumor or peptic stricture). The esophagoscope is left in place during the procedure to provide transillumination of the esophageal wall and periodic insufflation during the procedure to ensure the adequacy of the esophagomyotomy.
The trocar access used to accomplish the laparoscopic myotomy is arranged in 2 horizontal rows across the abdomen(Fig 1).
|
After the dissection of the right aspect of the distal esophagus is completed, the phrenoesophageal membrane over the left aspect of the distal esophagus is divided, including the upper gastrosplenic membranous attachments superior to the short gastric vessels. The left crus and the left lateral aspect of the distal esophagus are thereby exposed. The short gastric vessels along the greater curvature of the stomach are divided with the Harmonic Scalpel device (Ethicon Endo-Surgery, Inc, Cincinnati, Ohio) to the level of the left crus. This results in complete mobilization of the gastric fundus.
The esophagoscope is positioned under direct endoscopic vision to the level of the gastroesophageal junction. The esophagoscope is easily identified as the lighted tip transilluminates through the wall of the esophagus. We insufflate the lumen of the esophagus slightly to further assist in delineating the location of the obstruction at the gastroesophageal junction.
The esophagomyotomy is begun on the distal esophagus approximately 2 cm above the gastroesophageal junction(Figs 2 and3). Sharp dissection with the endoscopic scissors is augmented with monopolar electrocautery attached to this instrument. Once the mucosal layer is reached, the dissection is carried inferiorly and superiorly on the esophagus within this avascular plane. Periodic insufflation of the esophagoscope ensures that the mucosal layer is intact and that the dissections are proceeding in the proper plane. The esophagomyotomy is extended on the cardia of the stomach until the transverse venous plexus of the cardia is encountered. Simultaneous viewing of the lumen of the esophagus through the esophagoscope allows us to judge when the myotomy has been completed, as the rosette of mucosa that is seen at the distal esophageal obstruction becomes obliterated and free entry of the esophagoscope into the stomach is achieved. The myotomy is then widened by teasing the esophageal musculature from the mucosa to ensure that approximately 50% of the mucosal surface has been unroofed. As mentioned, the proximal extent of the myotomy is to the inferior pulmonary ligament as viewed through the diaphragmatic hiatus.
|
|
|
Intercostal access consists of 4 to 5 sites placed in 2 nearly parallel vertical rows. The anterior row is aligned along the anterior axillary line. The second row of intercostal access is aligned along a midaxillary to slightly posterior axillary line.
The fiberoptic esophagoscope is left in place during the myotomy procedure to assist in elevating the esophagus out of the posterior mediastinal bed and for transillumination and periodic insufflation of the esophageal lumen during the myotomy to ensure the integrity of the mucosa and the adequacy of the myotomy. The myotomy is begun at or slightly above the level of the inferior pulmonary ligament. It is extended on the distal esophagus to beyond the phrenoesophageal membrane so as to enter the coelomic cavity. We extend the esophagomyotomy on the cardia of the stomach to the level of the transverse venous plexus of this region of the stomach. We take care to avoid injury to the more distal oblique muscular sling fibers whose integrity is important in preserving competency of the antireflux mechanism. An antireflux procedure is not included with the myotomy when the thoracoscopic approach is used.
9,11,12
Follow-up.
Routine follow-up evaluation occurred in the early postoperative period (within 30 days of hospital discharge), 6 months after the operation, and then on an annual basis. At the return visits, symptoms were graded with regard to regurgitation, dysphagia, heartburn, chest pain, gas bloat, and diarrhea by means of a symptom analog scale ranging from 0 to 10. In addition, patients were asked to grade their "lifestyle change" and "overall sense of well-being" relative to their preoperative status using a similar 0-to-10 visual analog scale. These scores at 1 month, 6 months, and annually were compared with the patients preoperative symptoms. A postoperative symptom score similar to the system described by Jamieson and Duranceau
13 was also used to characterize the patients symptoms before and after repair of achalasia(Table I). In this scoring system, the frequency of symptoms is added to the duration of symptoms and the sum is multiplied by the severity of symptoms. A minimum score of 0 and a maximum score of 32 is possible. Symptom classification is as follows: mild (1-7), moderate (8-15), marked (16-23), and severe (24-32). The percent change from the patients preoperative scores was calculated. In addition to these symptom assessments, follow-up contrast esophagograms were obtained in 30 (52%) of the 58 patients, and follow-up manometry and pH testing were performed in 10 (17%) of the 58 patients.
|
| Results |
|---|
|
|
|---|
All patients described marked improvement or resolution of their dysphagia symptoms after the operation.Table II shows the symptom score based on a 0-to-10 scale on a variety of symptoms and lifestyle issues associated with achalasia. Chest pain, regurgitation, and dysphagia significantly improved after the operation, and diarrhea and gas bloat were unchanged. Overall sense of well-being and the overall symptom score
13 were significantly improved after the operation. The changes in symptoms, lifestyle, sense of well-being, and overall symptom scores were statistically significant, as noted inTable II
. Similarly, these changes were significantly different at various times analyzed postoperatively with dysphagia and regurgitation being statistically significant throughout the period of follow-up. According to the symptom score described by Jamieson and Duranceau,
13 our patients symptoms at 6 months, 1 year, and 2 years were significantly better than before the operation. Patients also described a significant improvement in their "lifestyles" and believed their overall "sense of well-being" was significantly better than before the operation. Six of the 46 patients with preoperative regurgitation had persistent postoperative regurgitation. Three patients had persistent chest pain after the operation.
|
Nine (16%) of the 58 patients described recurrence of dysphagia during the period of follow-up. Seven of the 9 patients with significant postoperative dysphagia were managed effectively with 1 or multiple bougie dilations (range 1-4). Two patients had severe recurrent dysphagia that was not amenable to dilation therapy. These 2 patients underwent a transhiatal esophagectomy 4 and 7 months after their minimally invasive myotomy.
| Comments |
|---|
|
|
|---|
The excellent intermediate term results, minimal postoperative pain, and the early recovery from the laparoscopic antireflux operation for medically refractory gastroesophageal reflux disease has changed the attitude of many patients and referring physicians regarding the primary surgical management of esophageal disorders, including gastroesophageal reflux disease and paraesophageal hiatal hernias.
19-21 A similar inclination has arisen regarding the use of minimally invasive thoracic surgical approaches for a wide variety of thoracic surgical problems, including esophageal achalasia. The improvements in the primary symptoms in our patients undergoing either laparoscopic or thoracoscopic approaches for achalasia confirm the findings of other investigators exploring these techniques.
22 Excellent control of dysphagia symptoms (96%) was noted in both thoracoscopic/laparoscopic esophagomyotomy cohorts. The results further confirm a favorable outcome with these minimally invasive surgical approaches that compares well against that seen for endoscopic pneumatic balloon therapy.
Despite the excellent initial improvement in dysphagia and symptom scores, 9 patients followed up between 8 and 72 months after the operation required esophageal dilation for symptoms of recurrent dysphagia. Seven of the 9 patients have had sustained improvement in their dysphagia with dilation alone. Two patients have required esophagectomy for recurrent symptoms refractory to intermittent dilation therapy. Late recurrence of dysphagia reinforces the need for long-term follow-up of these patients.
14,23 The fact that most patients with postoperative dysphagia requiring dilation had undergone a thoracoscopic myotomy may reflect a difficulty in performing an adequate distal myotomy by means of this technique. Only 1 patient who had a laparoscopic myotomy required postoperative dilation for recurrent dysphagia.
Subjective reflux symptoms after these minimally invasive approaches were infrequent, occurring in only 6 (10%) of the 58 patients. These acceptable results reflect our approach of routinely performing an antireflux procedure in patients undergoing a laparoscopic procedure and sparing the upper gastric sling fibers and most of the lateral phrenoesophageal attachments when performing thoracoscopic interventions. No difference was noted in postoperative reflux symptoms between patients undergoing thoracoscopic or laparoscopic procedures.
These minimally invasive procedures were primarily used to manage early to moderate disease or uncomplicated achalasia. Both of the patients requiring later esophagectomy in our series had significant esophageal dilatation and esophageal redundancy recognized in the preoperative period. The role of minimally invasive surgical management of patients with megaesophagus is not as yet determined. Patients with advanced achalasia may be better managed with primary esophageal resection.
As these minimally invasive approaches become more accepted in the management of esophageal disorders, the thoracic surgeons disengaged from these approaches may be left out of the management of these conditions with which they had historically been involved. Although the technical demands of these minimally invasive surgical approaches are similar to those of open surgical esophagomyotomy, it appears that these thoracoscopic techniques are a safe and effective alternative to open operations for the management of uncomplicated esophageal achalasia.
| Appendix: Discussion |
|---|
|
|
|---|
To come to this conclusion you have been using a visual analog scale to score the different symptoms and then incorporating these scores in the Jamieson-Duranceau scoring system by adding frequency and duration of symptoms. However, a substantial subset of your patients has not yet reached 2 years follow-up, which means that these patients cannot reach the 3- or 4-point mark in the duration of symptoms score. To a certain extent, this influences the final result in a favorable way. Indeed, at 2 years only a maximum score of 24 points can be reached against a maximum of 32 points before the operation, as the mean duration of symptoms was as much as 60 months. Moreover, as such a scoring system deals with the overall results from the entire group of patients, it acts like a smoke screen disguising the scores of each individual patient, which I think are much more relevant to evaluate. In fact, 6 patients continue to have regurgitation, 5 have symptoms suggesting reflux, and 3 continue to have chest pain. Furthermore, you mentioned 23 patients with postoperative loss of weight, with a mean of 5 kg, and as many as 9 patients (15%) required subsequent dilations, 2 of whom eventually had an esophagectomy. In my mind the true failure rate of the cardinal symptom, dysphagia, is 15%, illustrating a tendency of gradual degradation of the results over time.
Also troublesome is the lack of objective evaluation. Only 68% had a preoperative documented manometric diagnosis, and in the postoperative evaluation there were only 10 manometries and 24 pH studies, with no repeat on the results of the latter investigation. Therefore I think your conclusion is overly optimistic. Further careful follow-up is certainly required to evaluate whether this method really matches the results obtained in open operations.
I have 3 questions. First, this is a multi-institutional report dealing with 58 patients spread out over 5 institutions over 70 months. That means mathematically about 2 cases a year by each center. I would like to hear your comments about the problems of learning curves and how to avoid the pitfalls of such learning curves.
Second, what is supposed to be the cause of recurrent dysphagia? Was there any difference between the thoracoscopic and laparoscopic approaches, the Toupet or the Dor antiplatelet procedure, or in patients who had previous pneumatic dilations? Why did you not perform a second myotomy rather than an esophagectomy, unless the esophagectomy was already indicated at the first operation?
Third, did you find any morphologic differences in those patients who had previous pneumatic dilations and/or the number of those dilations? Is the operation more difficult in those patients? In other words, does pneumatic dilation unfavorably affect the indication for minimally invasive approaches? This eventually would be an argument favoring surgery over pneumatic dilation.
Dr Wiechmann. I agree that careful follow-up is certainly necessary in this group of patients. In response to your questions, I think there is a learning curve. In fact, our numbers at all institutions increased significantly with time, and there was clearly a progression of the procedure with time. As to avoiding pitfalls of the learning curve, as we become more experienced with all laparoscopic and thoracoscopic techniques, then we are able to avoid the pitfalls of this procedure. It is essential to understand the pathophysiology of achalasia and to be accomplished in the open management of this disease process before one begins to use minimally invasive techniques.
Was there a difference in dysphagia between the patients who underwent a thoracoscopic or a laparoscopic approach? We compared the patients who had undergone a thoracoscopic and laparoscopic approach with this question in mind and did not find a significant difference in postoperative dysphagia. There was a slight difference in operative time but no significant difference in efficacy of the procedure. The 2 (13%) patients who underwent an esophagectomy had rather advanced disease with significant tortuosity and more of a "sink trap esophagus." Our experience with these 2 patients led us to the conclusion that this procedure would be better attempted in patients with uncomplicated achalasia and without significant tortuosity. In fact, 2 patients who had significant tortuosity and underwent a minimally invasive procedure did later require esophagectomy because of failure of the procedure.
Was there a difference in patients who had preoperative dilations? Most of our patients did undergo preoperative dilation, and I do not believe surgery was more difficult in those who had undergone dilation and those that had not. Therefore I do not believe that patients who undergo preoperative dilation should be excluded from undergoing a minimally invasive procedure, nor are their operations significantly more difficult.
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
M. G. Patti, D. Molena, P. M. Fisichella, K. Whang, H. Yamada, S. Perretta, and L. W. Way Laparoscopic Heller Myotomy and Dor Fundoplication for Achalasia: Analysis of Successes and Failures Arch Surg, August 1, 2001; 136(8): 870 - 877. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |